E
Balance Labs, Inc.
BLNC
$0.2122
$0.029115.89%
E
Sell
1/4/2024Upgraded
Balance Labs, Inc. (BLNC) was upgraded to E+ from E- on 1/4/2024 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0045 to -$0.0032, EBIT increased 16.26% from -$41.2 to -$34.5, and operating cash flow increased 4.91% from -$38.7 to -$36.8.
Balance Labs, Inc. (BLNC) was upgraded to E+ from E- on 1/4/2024 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0045 to -$0.0032, EBIT increased 16.26% from -$41.2 to -$34.5, and operating cash flow increased 4.91% from -$38.7 to -$36.8.
E
Sell
11/1/2023Downgrade
Balance Labs, Inc. (BLNC) was downgraded to E- from E+ on 11/1/2023 due to a decline in the solvency index, growth index and valuation index. Operating cash flow declined 172.54% from -$14.2 to -$38.7, EBIT declined 13.5% from -$36.3 to -$41.2, and earnings per share declined from -$0.004 to -$0.0045.
Balance Labs, Inc. (BLNC) was downgraded to E- from E+ on 11/1/2023 due to a decline in the solvency index, growth index and valuation index. Operating cash flow declined 172.54% from -$14.2 to -$38.7, EBIT declined 13.5% from -$36.3 to -$41.2, and earnings per share declined from -$0.004 to -$0.0045.
E
Sell
3/14/2023Downgrade
Balance Labs, Inc. (BLNC) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
Balance Labs, Inc. (BLNC) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/23/2023Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D- from E+ on 02/23/2023.
Balance Labs, Inc. (BLNC) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
Balance Labs, Inc. (BLNC) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the total return index and volatility index.
Balance Labs, Inc. (BLNC) was downgraded to E+ from D- on 2/8/2023 due to a noticeable decline in the total return index and volatility index.
D
Sell
1/4/2023Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 1/4/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from -0.64 to -0.62.
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 1/4/2023 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from -0.64 to -0.62.
D
Sell
8/25/2022Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 8/25/2022 due to an increase in the solvency index and valuation index. The quick ratio increased from 0.07 to 0.07.
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 8/25/2022 due to an increase in the solvency index and valuation index. The quick ratio increased from 0.07 to 0.07.
D
Sell
5/16/2022Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D- from E+ on 5/16/2022 due to an increase in the volatility index.
Balance Labs, Inc. (BLNC) was upgraded to D- from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
Balance Labs, Inc. (BLNC) was downgraded to E+ from D- on 05/01/2022.
Balance Labs, Inc. (BLNC) was downgraded to E+ from D- on 05/01/2022.
D
Sell
4/29/2022Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D- from C on 4/29/2022 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 213.83% from $3.13M to -$3.56M, and total capital declined 136.74% from $2.58M to -$949.
Balance Labs, Inc. (BLNC) was downgraded to D- from C on 4/29/2022 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 213.83% from $3.13M to -$3.56M, and total capital declined 136.74% from $2.58M to -$949.
C
Hold
3/21/2022Upgraded
Balance Labs, Inc. (BLNC) was upgraded to C from C- on 3/21/2022 due to an increase in the total return index and volatility index.
Balance Labs, Inc. (BLNC) was upgraded to C from C- on 3/21/2022 due to an increase in the total return index and volatility index.
C
Hold
3/2/2022Downgrade
Balance Labs, Inc. (BLNC) was downgraded to C- from C on 3/2/2022 due to a substantial decline in the total return index.
Balance Labs, Inc. (BLNC) was downgraded to C- from C on 3/2/2022 due to a substantial decline in the total return index.
C
Hold
11/22/2021Upgraded
Balance Labs, Inc. (BLNC) was upgraded to C from D+ on 11/22/2021 due to a significant increase in the valuation index, solvency index and total return index. The quick ratio increased from 0.03 to 0.06.
Balance Labs, Inc. (BLNC) was upgraded to C from D+ on 11/22/2021 due to a significant increase in the valuation index, solvency index and total return index. The quick ratio increased from 0.03 to 0.06.
D
Sell
9/28/2021Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 9/28/2021 due to a noticeable increase in the total return index.
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 9/28/2021 due to a noticeable increase in the total return index.
D
Sell
8/18/2021Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 8/18/2021 due to a major decline in the valuation index, solvency index and efficiency index. Total capital declined 3.37% from -$397.1 to -$410.5, and net income declined 0.61% from -$181.4 to -$182.5.
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 8/18/2021 due to a major decline in the valuation index, solvency index and efficiency index. Total capital declined 3.37% from -$397.1 to -$410.5, and net income declined 0.61% from -$181.4 to -$182.5.
D
Sell
8/16/2021Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 8/16/2021 due to a major increase in the valuation index and volatility index.
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 8/16/2021 due to a major increase in the valuation index and volatility index.
D
Sell
7/26/2021Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 7/26/2021 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 188.46% from -$44.2 to -$127.5, earnings per share declined from $0.0396 to -$0.01, and EBIT declined 110.47% from $910.3 to -$95.3.
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 7/26/2021 due to a substantial decline in the growth index, total return index and volatility index. Operating cash flow declined 188.46% from -$44.2 to -$127.5, earnings per share declined from $0.0396 to -$0.01, and EBIT declined 110.47% from $910.3 to -$95.3.
D
Sell
4/8/2021Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 4/8/2021 due to a significant increase in the efficiency index, growth index and valuation index. EBIT increased 1,153.59% from -$86.4 to $910.3, earnings per share increased from -$0.0124 to $0.0396, and net income increased 418.69% from -$269.1 to $857.6.
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 4/8/2021 due to a significant increase in the efficiency index, growth index and valuation index. EBIT increased 1,153.59% from -$86.4 to $910.3, earnings per share increased from -$0.0124 to $0.0396, and net income increased 418.69% from -$269.1 to $857.6.
D
Sell
3/5/2021Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 3/5/2021 due to a large increase in the total return index, volatility index and growth index. Operating cash flow increased 19.94% from -$67.2 to -$53.8, and EBIT increased 9.91% from -$95.9 to -$86.4.
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 3/5/2021 due to a large increase in the total return index, volatility index and growth index. Operating cash flow increased 19.94% from -$67.2 to -$53.8, and EBIT increased 9.91% from -$95.9 to -$86.4.
D
Sell
5/1/2020Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, volatility index and total return index.
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 5/1/2020 due to a significant decline in the efficiency index, volatility index and total return index.
D
Sell
4/15/2020Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 4/15/2020 due to a significant decline in the solvency index and total return index.
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 4/15/2020 due to a significant decline in the solvency index and total return index.
D
Sell
3/31/2020Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 3/31/2020 due to an increase in the volatility index and growth index.
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 3/31/2020 due to an increase in the volatility index and growth index.
D
Sell
1/29/2020Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 1/29/2020 due to a decline in the volatility index, total return index and growth index.
Balance Labs, Inc. (BLNC) was downgraded to D from D+ on 1/29/2020 due to a decline in the volatility index, total return index and growth index.
D
Sell
11/15/2019Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 11/15/2019 due to a significant increase in the efficiency index and total return index.
Balance Labs, Inc. (BLNC) was upgraded to D+ from D on 11/15/2019 due to a significant increase in the efficiency index and total return index.
D
Sell
8/15/2019Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 8/15/2019 due to a noticeable increase in the growth index. EBIT increased 44.4% from -$202.5 to -$112.6, earnings per share increased from -$0.0115 to -$0.01, and operating cash flow increased 11.1% from -$109.9 to -$97.7.
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 8/15/2019 due to a noticeable increase in the growth index. EBIT increased 44.4% from -$202.5 to -$112.6, earnings per share increased from -$0.0115 to -$0.01, and operating cash flow increased 11.1% from -$109.9 to -$97.7.
D
Sell
5/16/2019Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 5/16/2019 due to a noticeable decline in the growth index, efficiency index and total return index. EBIT declined 55.29% from -$130.4 to -$202.5, earnings per share declined from -$0.0076 to -$0.0115, and total revenue declined 50.75% from $6.7 to $3.3.
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 5/16/2019 due to a noticeable decline in the growth index, efficiency index and total return index. EBIT declined 55.29% from -$130.4 to -$202.5, earnings per share declined from -$0.0076 to -$0.0115, and total revenue declined 50.75% from $6.7 to $3.3.
D
Sell
12/14/2018Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 12/14/2018 due to an increase in the growth index, efficiency index and total return index. Earnings per share increased from -$0.0128 to -$0.0092, net income increased 27.96% from -$275.8 to -$198.7, and operating cash flow increased 19.82% from -$112.5 to -$90.2.
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 12/14/2018 due to an increase in the growth index, efficiency index and total return index. Earnings per share increased from -$0.0128 to -$0.0092, net income increased 27.96% from -$275.8 to -$198.7, and operating cash flow increased 19.82% from -$112.5 to -$90.2.
D
Sell
8/9/2018Downgrade
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 8/9/2018 due to a decline in the efficiency index, total return index and valuation index. Net income declined 416.28% from $87.2 to -$275.8, and total capital declined 64.86% from -$231.9 to -$382.3.
Balance Labs, Inc. (BLNC) was downgraded to D- from D on 8/9/2018 due to a decline in the efficiency index, total return index and valuation index. Net income declined 416.28% from $87.2 to -$275.8, and total capital declined 64.86% from -$231.9 to -$382.3.
D
Sell
3/29/2018Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 3/29/2018 due to a major increase in the efficiency index, volatility index and total return index.
Balance Labs, Inc. (BLNC) was upgraded to D from D- on 3/29/2018 due to a major increase in the efficiency index, volatility index and total return index.
D
Sell
5/31/2017Upgraded
Balance Labs, Inc. (BLNC) was upgraded to D- from E+ on 5/31/2017 due to a noticeable increase in the valuation index, growth index and total return index. Operating cash flow increased 54.25% from -$156.3 to -$71.5, EBIT increased 41.68% from -$248.1 to -$144.7, and earnings per share increased from -$0.0193 to -$0.0146.
Balance Labs, Inc. (BLNC) was upgraded to D- from E+ on 5/31/2017 due to a noticeable increase in the valuation index, growth index and total return index. Operating cash flow increased 54.25% from -$156.3 to -$71.5, EBIT increased 41.68% from -$248.1 to -$144.7, and earnings per share increased from -$0.0193 to -$0.0146.
E
Sell
11/1/2016Upgraded
Balance Labs, Inc. (BLNC) was upgraded to E+ from E on 11/1/2016 due to a major increase in the solvency index. The quick ratio increased from 0 to 0.49.
Balance Labs, Inc. (BLNC) was upgraded to E+ from E on 11/1/2016 due to a major increase in the solvency index. The quick ratio increased from 0 to 0.49.
E
Sell
8/16/2016Downgrade
Balance Labs, Inc. (BLNC) was downgraded to E from E+ on 8/16/2016 due to a significant decline in the volatility index and total return index.
Balance Labs, Inc. (BLNC) was downgraded to E from E+ on 8/16/2016 due to a significant decline in the volatility index and total return index.
E
Sell
8/1/2016Upgraded
Balance Labs, Inc. (BLNC) was upgraded to E+ from E on 8/1/2016 due to a large increase in the total return index and growth index. Operating cash flow increased 32.77% from -$70.5 to -$47.4, EBIT increased 18.48% from -$123.9 to -$101, and earnings per share increased from -$0.0061 to -$0.0058.
Balance Labs, Inc. (BLNC) was upgraded to E+ from E on 8/1/2016 due to a large increase in the total return index and growth index. Operating cash flow increased 32.77% from -$70.5 to -$47.4, EBIT increased 18.48% from -$123.9 to -$101, and earnings per share increased from -$0.0061 to -$0.0058.
E
Sell
5/10/2016None
Balance Labs, Inc. (BLNC) was downgraded to E from U on 05/10/2016.
Balance Labs, Inc. (BLNC) was downgraded to E from U on 05/10/2016.
OTC PK
12/19/2024 10:09AM Eastern
Quotes delayed
